[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
About the Journal
Editorial Board
Aims& Scopes
Journal News
Articles archive::
All Issues
Current Issue
Publication Ethics::
Peer Review Process::
Indexing Databases::
For Authors::
Authors Guideline
Call for Papers
Submission Instruction
Review Process
Research Ethics Statements
Ethical issues
Author Complaint Process
For Reviewers::
Reviewers Section
Subscription::
Registration Information
Subscription Form
Contact us::
Contact Information
Contact us
Site Facilities::
Site map
Search contents
FAQ
Top 10 contents
Inform to friends
::
Google Scholar Metrics

Citation Indices from GS

AllSince 2019
Citations68634096
h-index2822
i10-index20599
..
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Registered in

AWT IMAGE

AWT IMAGE
..
:: Volume 32, Issue 5 (12-2024) ::
Journal of Ilam University of Medical Sciences 2024, 32(5): 92-105 Back to browse issues page
Cytotoxicity Effect of Bifidobacterium bifidum probiotic Cell Extract and supernatants on Adenocarcinoma gastric Cancer Cell Line and Analysis of some Apoptosis Genes Expression
Hanieh Hemmatian1 , Ali Sharifzadeh * 2, Faranak Aali3
1- Dept of Biology, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran
2- Dept of Microbiology, Faculty of Veterinary Medicine, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran , alisharifzadeh10@gmail.com
3- Biotechnology Research Center, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran
Abstract:   (124 Views)
Introduction:  Cancer is considered one of the most significant causes of death worldwide. Probiotics are living microbes that play a significant role in protecting the host in various ways. The aim of this study was to investigate the cytotoxic effect of Bifidobacterium bifidum cell extract and supernatants as probiotic bacteria on the Adenocarcinoma gastric cancer cell line and analysis of Fas, P53, and Bcl2 gene expression.
Materials & Methods: In this experimental study, the cell extract of heat-killed and supernatants Bifidobacterium bifidum was prepared. The cytotoxicity of cell extract and supernatants on AGS cell lines was evaluated in 24, 48, and 72 hours using a cytotoxicity assay. Moreover, the P53, Bcl2, and Fas apoptosis gene expression levels in the Adenocarcinoma gastric cancer cell line were analyzed using a molecular assay. The collected data were statistically analyzed using one-way ANOVA analysis with the Graph Pad Prism V.8 at the level of significance less than 0.05.
Results: Supernatant (pH = 6), then supernatant (pH = 4), and then cell extracts of Bifidobacterium bifidum were able to reduce the survival rate of the AGS cell line in 48 and 72 hours. The results of gene expression by molecular method also showed an increase in Fas and P53 gene expression (p < 0.05) and a decrease in Bcl2 gene expression (p < 0.05) in the adenocarcinoma gastric cancer cell line compared to the reference GAPDH gene expression after 72 hours.
Conclusion: Supernatant of Bifidobacterium bifidum with, respectively, pH = 6 and pH = 4, could induce apoptosis in the Adenocarcinoma gastric cancer cell line. So, it seems that Bifidobacterium bifidum has potential uses as a probiotic for pharmaceutical applications, including the prevention of gastric cancer.
 
Keywords: Gastric Cancer, Apoptosis, Probiotic
Full-Text [PDF 886 kb]   (73 Downloads)    
Type of Study: Research | Subject: Bacteriology
Received: 2024/01/28 | Accepted: 2024/06/16 | Published: 2024/12/5
References
1. Semnani S, Besharat S, Arabali A, Kestkar AA, Roshandel Gh, Abdolahi N, et al. Relation between drinking water hardness and the incidence of esophageal and gastric cancers. J Gorgan Univ Med Sci 2009; 11:76-80.
2. IW CD, Jaia CJ. Gastric cancer epidemiology: current trend and future direction. Hygiene 2023; 3:256-68. doi:10.3390/hygiene3030019.
3. Eom SS, Choi W, Eom BW, Park SH, Kim SJ, Kim YI, et al. A Comprehensive and Comparative Review of Global Gastric Cancer Treatment Guidelines. J Gastric Cancer 2022; 22:3-23. doi: 10.5230/jgc.2022.22. e10.
4. Wang F, Li T, Zhang B, Li H, Wu Q, Yang L, et al. MicroRNA- 19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN. Biochem Biophys Res Commun 2013; 434:688-94. doi: 10.1016/j.bbrc.2013.04.010.
5. Mocan L. Surgical Management of Gastric Cancer: A Systematic Review. J Clin Med 2021; 10:2557. doi: 10.3390/jcm10122557.
6. Lang SA, Gaumann A, Koehl GE, Seidel U, Bataille F, Klein D, et al. Mammalian target of rapamycin is activated in human gastric cancer and serves as a target for therapy in an experimental model. Int J Cancer 2007; 120:1803-10. doi: 10.1002/ijc.22442.
7. Guan WL, He Y, Xu RH. Gastric cancer treatment: recent progress and future perspectives. J Hematol Oncol 2023; 16:57. doi: 10.1186/s13045-023-01451-3.
8. Panda SK, Sahoo PK, Agarwala SK, Houghton TT, Chandrapattan PP, Sankar KV, et al. Evolution of treatment in gastric cancer- a systematic review. J Egypt Natl Canc Inst 2022; 34:12. doi: 10.1186/s43046-022-00114-7.
9. Wong H, Yau T. Molecular targeted therapies in advanced gastric cancer: does tumor histology matter? Therap Adv Gastroenterol 2013; 6:15-31. doi: 10.1177/1756283X12453636.
10. Yaghoobi H, Bandeh poor M, Kazemi B. 2016.Application of bacteria in the treatment of cancer. New Cell Biotech Mol 2016; 26:96-100[Persian].
11. Slizewska K, Kopec PM, Slizewska W. The roles of probiotics in cancer prevention. Cancers 2021; 13: 1-22. doi: 10.3390/cancers13010020.
12. Kumar A, Pramanik J, Goyal N, Chauhan D, Sivamaruthi BS, Prajapati BG, et al. Gut Microbiota in Anxiety and Depression: Unveiling the Relationships and Management Options. Pharmaceuticals 2023;16:565. doi: 10.3390/ph16040565.
13. Faghfoori Z, Faghfoori MH, Saber A, Izadi A, Yari Khosroushahi A. Anticancer effects of bifidobacteria on colon cancer cell lines. Cancer Cell Int 2021; 21:258. doi: 10.1186/s12935-021-01971-3.
14. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin 2023; 73:17-48. doi: 10.3322/caac.21763.
15. Araghi M, Soerjomataram I, Jenkins M, Brierley J, Morris E, Bray F, et al. Global trends in colorectal cancer mortality: projections to the year 2035. Int J Cancer 2019; 144:2992-3000. doi: 10.1002/ijc.32055.
16. Brenner AT, Dougherty M, Reuland DS. Colorectal cancer screening in average risk patients. Med Clin North Am 2017; 101:755-67. doi: 10.1016/j.mcna.2017.03.007.
17. Asadollahi P, Ghanavati R, Rouhani M, Razavi S, Esghaei M, Talebi M. Anticancer efects of Bifdobacterium species in colon cancer cells and a mouse model of carcinogenesis. PloS One 2020; 15:1-18. doi: 10.1371/journal.pone.0232930.
18. Nowak A, Paliwoda A, Błasiak J. Anti-proliferative, pro-apoptotic and antioxidative activity of Lactobacillus and Bifdobacterium strains: A review of mechanisms and therapeutic perspectives. Crit Rev Food Sci Nutr 2019;59:3456-67. doi: 10.1080/10408398.2018.1494539.
19. Tiptiri-Kourpeti A, Spyridopoulou K, Santarmaki V, Aindelis G, Tompoulidou E, Lamprianidou EE, et al. Lactobacillus casei exerts anti-proliferative efects accompanied by apoptotic cell death and up-regulation of TRAIL in colon carcinoma cells. PLoS One 2016; 11:e0147960. doi: 10.1371/journal.pone.0147960.
20. Fahmy CA, Gamal-Eldeen AM, El-Hussieny EA, Raafat BM, Mehanna NS, Talaat RM, et al. Bifdobacterium longum suppresses murine colorectal cancer through the modulation of oncomirs and tumor suppressor mirnas. Nutr Cancer 2019; 71:688-700. doi: 10.1080/01635581.2019.1577984.
21. Miller LE, Lehtoranta L, Lehtinen MJ. 2017. The efect of Bifdobacterium animalis ssp. lactis HN019 on cellular immune function in healthy elderly subjects: systematic review and meta-analysis. Nutrients 2017; 9:191. doi: 10.3390/nu9030191.
22. Zhong L, Zhang X, Covasa M. Emerging roles of lactic acid bacteria in protection against colorectal cancer. World J Gastroenterol 2014; 20:7878-86. doi: 10.3748/wjg.v20.i24.7878.
23. Zarei L, Abtahim M, Karaje Daghi A, Ismaili H. Direct effect of bifidobacterium cell wall extract on the proliferation of K562 cancer cell line. J Fasa Univ Med Sci 2016; 7:21-27.
24. Kato S, Hamouda N, Kano Y, Oikawa Y, Tanaka Y, Matsumoto K, et al . Probiotic Bifidobacterium bifidum G9-1 attenuates 5-fluorouracil-induced intestinal mucositis in mice via suppression of dysbiosis-related secondary inflammatory responses. Clin Exp Pharmacol Physiol 2017;44:1017-25. doi: 10.1111/1440-1681.12792.
25. Wei H, Chen L, Lian G, Yang J, Li F, Zou Y, et al. Antitumor mechanisms of bifidobacteria(review). Oncol Lett 2018; 16:3-8. doi: 10.3892/ol.2018.8692.
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA

Ethics code: IR.IAU.SHK.REC.1401.120

XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Hemmatian H, Sharifzadeh A, Aali F. Cytotoxicity Effect of Bifidobacterium bifidum probiotic Cell Extract and supernatants on Adenocarcinoma gastric Cancer Cell Line and Analysis of some Apoptosis Genes Expression. J. Ilam Uni. Med. Sci. 2024; 32 (5) :92-105
URL: http://sjimu.medilam.ac.ir/article-1-8223-en.html
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 32, Issue 5 (12-2024) Back to browse issues page
مجله دانشگاه علوم پزشکی ایلام Journal of Ilam University of Medical Sciences
Persian site map - English site map - Created in 0.15 seconds with 41 queries by YEKTAWEB 4671